Zealand Pharma — Februar 2022
-
Flere detaljer mht. Gvoke TRx & Revenue:
Gvoke Sales Tracker - XerisDD
Weekly TRx Sales Tracker - Gvoke vs Baqsimi
XerisDD - A Community of Due Diligence on $XERS (xerisdd.com)
-
Mange tak exitnu.
-
Bemærk i øvrigt, at reglerne for indberetning af short nu er 0,1 % mod tidligere (med visse undtagelser) 0,2 %.....
-
Det har jeg ellers været glad for, men tak for dit arbejde med det.
-
Here's How Healthcare Stocks Have Historically Performed After a Down January https://www.proinvestor.com/investornyt/780839/heres-how-healthcare-stocks-have-historically-performed-after-a-down-january
-
@DeltaFlyer - selv tak.
-
Shorterne er gode til at fastholde lavere kurser, hvis der ikke snart er nogle der begynder at købe falder den under 100, de skal vel købes hjen på et tidspunkt
-
In their previous filing dated January 29, 2021, the investor reported owning 7,238,424 shares and 18.20 percent of the company, indicating an increase in shares of 1.15 percent and a decrease in total ownership of 7.69 percent. The investor has filed 2 13D or G filings since January 29, 2021.
-
Jep, det betrygger da i den grad casen Zealand Pharma
-
Tak for diverse info
-
Zealand Pharma har rekrutteret alle til fase 3-studie - NY https://proinvestor.com/investornyt/781647/zealand-pharma-har-rekrutteret-alle-til-fase-3-studie-ny
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind